https://stock.noler.com/us/stock/bioclinica-inc https://stock.noler.com/us/stock/bioclinica-inc/accounts-payable https://stock.noler.com/us/stock/bioclinica-inc/accounts-receivable https://stock.noler.com/us/stock/bioclinica-inc/accrued-liabilities-current https://stock.noler.com/us/stock/bioclinica-inc/accrued-professional-fees-current https://stock.noler.com/us/stock/bioclinica-inc/accumulated-depreciation https://stock.noler.com/us/stock/bioclinica-inc/accumulated-oci-cumulative-changes-in-net-gain-loss-from-cash-flow-hedges-effect-net-of-tax https://stock.noler.com/us/stock/bioclinica-inc/acquisition-acquisition-related-costs https://stock.noler.com/us/stock/bioclinica-inc/acquisitions https://stock.noler.com/us/stock/bioclinica-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/bioclinica-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/bioclinica-inc/additional-paid-in-capital https://stock.noler.com/us/stock/bioclinica-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/bioclinica-inc/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/bioclinica-inc/allowance-for-doubtful-accounts-receivable-charge-offs https://stock.noler.com/us/stock/bioclinica-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/bioclinica-inc/amended-reports-10-k https://stock.noler.com/us/stock/bioclinica-inc/amortization https://stock.noler.com/us/stock/bioclinica-inc/amortization-of-acquired-intangible-assets https://stock.noler.com/us/stock/bioclinica-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/bioclinica-inc/aoci https://stock.noler.com/us/stock/bioclinica-inc/basic-shares https://stock.noler.com/us/stock/bioclinica-inc/billed-contract-receivables https://stock.noler.com/us/stock/bioclinica-inc/business-acquisition-cost-of-acquired-entity-cash-paid https://stock.noler.com/us/stock/bioclinica-inc/business-acquisition-cost-of-acquired-entity-equity-interests-issued-and-issuable https://stock.noler.com/us/stock/bioclinica-inc/business-acquisition-cost-of-acquired-entity-liabilities-incurred https://stock.noler.com/us/stock/bioclinica-inc/business-acquisition-cost-of-acquired-entity-purchase-price https://stock.noler.com/us/stock/bioclinica-inc/business-acquisition-equity-interest-issued-or-issuable-value-assigned https://stock.noler.com/us/stock/bioclinica-inc/business-acquisition-equity-interests-issued-or-issuable-number-of-shares-issued https://stock.noler.com/us/stock/bioclinica-inc/business-acquisition-pro-forma-earnings-per-share-basic https://stock.noler.com/us/stock/bioclinica-inc/business-acquisition-pro-forma-earnings-per-share-diluted https://stock.noler.com/us/stock/bioclinica-inc/business-acquisition-purchase-price-allocation-current-liabilities-other-liabilities https://stock.noler.com/us/stock/bioclinica-inc/business-acquisition-purchase-price-allocation-liabilities-assumed https://stock.noler.com/us/stock/bioclinica-inc/business-acquisition-purchase-price-allocation-other-noncurrent-assets https://stock.noler.com/us/stock/bioclinica-inc/business-acquisition-purchase-price-allocation-property-plant-and-equipment https://stock.noler.com/us/stock/bioclinica-inc/business-acquisition-share-price https://stock.noler.com/us/stock/bioclinica-inc/business-acquisitions-pro-forma-income-loss-from-before-changes-in-accounting-and-extraordinary-items-net-of-tax https://stock.noler.com/us/stock/bioclinica-inc/business-acquisitions-pro-forma-net-income-loss https://stock.noler.com/us/stock/bioclinica-inc/business-acquisitions-pro-forma-revenue https://stock.noler.com/us/stock/bioclinica-inc/business-exit-costs https://stock.noler.com/us/stock/bioclinica-inc/buybacks-payments-for-repurchase-of-equity https://stock.noler.com/us/stock/bioclinica-inc/buybacks-treasury-stock-cost https://stock.noler.com/us/stock/bioclinica-inc/capital-expenditures https://stock.noler.com/us/stock/bioclinica-inc/capital-lease-obligations-current https://stock.noler.com/us/stock/bioclinica-inc/capital-lease-obligations-incurred https://stock.noler.com/us/stock/bioclinica-inc/capital-lease-obligations-noncurrent https://stock.noler.com/us/stock/bioclinica-inc/capital-leases-future-minimum-payments-due https://stock.noler.com/us/stock/bioclinica-inc/capital-leases-future-minimum-payments-due-in-rolling-year-five https://stock.noler.com/us/stock/bioclinica-inc/capital-leases-future-minimum-payments-due-in-rolling-year-four https://stock.noler.com/us/stock/bioclinica-inc/capital-leases-future-minimum-payments-due-in-rolling-year-three https://stock.noler.com/us/stock/bioclinica-inc/capital-leases-future-minimum-payments-due-in-rolling-year-two https://stock.noler.com/us/stock/bioclinica-inc/capital-leases-future-minimum-payments-next-rolling-twelve-months https://stock.noler.com/us/stock/bioclinica-inc/capitalized-computer-software-accumulated-amortization https://stock.noler.com/us/stock/bioclinica-inc/capitalized-computer-software-additions https://stock.noler.com/us/stock/bioclinica-inc/capitalized-computer-software-amortization https://stock.noler.com/us/stock/bioclinica-inc/cash-acquired-from-acquisition https://stock.noler.com/us/stock/bioclinica-inc/cash-and-equivalents https://stock.noler.com/us/stock/bioclinica-inc/cash-flow-breakdown https://stock.noler.com/us/stock/bioclinica-inc/clinical-trials https://stock.noler.com/us/stock/bioclinica-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/bioclinica-inc/common-stock-value https://stock.noler.com/us/stock/bioclinica-inc/comprehensive-income https://stock.noler.com/us/stock/bioclinica-inc/cost-of-reimbursable-expense https://stock.noler.com/us/stock/bioclinica-inc/cost-of-services https://stock.noler.com/us/stock/bioclinica-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/bioclinica-inc/cumulative-translation-adjustment-net-of-tax-change https://stock.noler.com/us/stock/bioclinica-inc/current-assets https://stock.noler.com/us/stock/bioclinica-inc/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/bioclinica-inc/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/bioclinica-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/bioclinica-inc/current-liabilities https://stock.noler.com/us/stock/bioclinica-inc/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/bioclinica-inc/debt-basis-spread-on-variable-rate https://stock.noler.com/us/stock/bioclinica-inc/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/bioclinica-inc/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/bioclinica-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/bioclinica-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/bioclinica-inc/deferred-revenue https://stock.noler.com/us/stock/bioclinica-inc/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/bioclinica-inc/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/bioclinica-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/bioclinica-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/bioclinica-inc/deferred-tax-assets-net-current https://stock.noler.com/us/stock/bioclinica-inc/deferred-tax-assets-net-noncurrent https://stock.noler.com/us/stock/bioclinica-inc/deferred-tax-assets-other https://stock.noler.com/us/stock/bioclinica-inc/deferred-tax-assets-state-taxes https://stock.noler.com/us/stock/bioclinica-inc/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/bioclinica-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/bioclinica-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/bioclinica-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-deferred-rent https://stock.noler.com/us/stock/bioclinica-inc/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-restructuring-charges https://stock.noler.com/us/stock/bioclinica-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/bioclinica-inc/deferred-tax-liabilities-current https://stock.noler.com/us/stock/bioclinica-inc/deferred-tax-liabilities-noncurrent https://stock.noler.com/us/stock/bioclinica-inc/deferred-tax-liabilities-other https://stock.noler.com/us/stock/bioclinica-inc/deferred-tax-liabilities-prepaid-expenses https://stock.noler.com/us/stock/bioclinica-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/bioclinica-inc/depreciation https://stock.noler.com/us/stock/bioclinica-inc/depreciation-and-amortization https://stock.noler.com/us/stock/bioclinica-inc/derivative-net-hedge-ineffectiveness-gain-loss https://stock.noler.com/us/stock/bioclinica-inc/derivative-notional-amount https://stock.noler.com/us/stock/bioclinica-inc/derivative-number-of-instruments-held https://stock.noler.com/us/stock/bioclinica-inc/diluted-shares https://stock.noler.com/us/stock/bioclinica-inc/effective-tax-rate https://stock.noler.com/us/stock/bioclinica-inc/employee-related-liabilities-current https://stock.noler.com/us/stock/bioclinica-inc/eps https://stock.noler.com/us/stock/bioclinica-inc/eps-basic https://stock.noler.com/us/stock/bioclinica-inc/excess-tax-benefit-from-share-based-compensation-financing-activities https://stock.noler.com/us/stock/bioclinica-inc/excess-tax-benefit-from-share-based-compensation-operating-activities https://stock.noler.com/us/stock/bioclinica-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/bioclinica-inc/financing-cash-flow https://stock.noler.com/us/stock/bioclinica-inc/finite-lived-customer-relationships-gross https://stock.noler.com/us/stock/bioclinica-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/bioclinica-inc/finite-lived-intangible-assets-amortization-expense-next-rolling-twelve-months https://stock.noler.com/us/stock/bioclinica-inc/finite-lived-intangible-assets-amortization-expense-rolling-after-year-five https://stock.noler.com/us/stock/bioclinica-inc/finite-lived-intangible-assets-amortization-expense-rolling-year-five https://stock.noler.com/us/stock/bioclinica-inc/finite-lived-intangible-assets-amortization-expense-rolling-year-four https://stock.noler.com/us/stock/bioclinica-inc/finite-lived-intangible-assets-amortization-expense-rolling-year-three https://stock.noler.com/us/stock/bioclinica-inc/finite-lived-intangible-assets-amortization-expense-rolling-year-two https://stock.noler.com/us/stock/bioclinica-inc/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/bioclinica-inc/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/bioclinica-inc/foreign-currency-contract-asset-fair-value-disclosure https://stock.noler.com/us/stock/bioclinica-inc/foreign-earnings https://stock.noler.com/us/stock/bioclinica-inc/foreign-pretax-income https://stock.noler.com/us/stock/bioclinica-inc/gain-loss-on-derivative-instruments-net-pretax https://stock.noler.com/us/stock/bioclinica-inc/general-and-administrative-expense https://stock.noler.com/us/stock/bioclinica-inc/goodwill https://stock.noler.com/us/stock/bioclinica-inc/income-tax https://stock.noler.com/us/stock/bioclinica-inc/income-tax-expense-benefit https://stock.noler.com/us/stock/bioclinica-inc/income-taxes-paid https://stock.noler.com/us/stock/bioclinica-inc/increase-decrease-in-accounts-payable-trade https://stock.noler.com/us/stock/bioclinica-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/bioclinica-inc/increase-decrease-in-accrued-liabilities-and-other-operating-liabilities https://stock.noler.com/us/stock/bioclinica-inc/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/bioclinica-inc/increase-decrease-in-other-operating-assets https://stock.noler.com/us/stock/bioclinica-inc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/bioclinica-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/bioclinica-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/bioclinica-inc/insider-transactions-other https://stock.noler.com/us/stock/bioclinica-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/bioclinica-inc/insider-transactions-stock-units https://stock.noler.com/us/stock/bioclinica-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/bioclinica-inc/interest-expense https://stock.noler.com/us/stock/bioclinica-inc/interest-paid https://stock.noler.com/us/stock/bioclinica-inc/investing-cash-flow https://stock.noler.com/us/stock/bioclinica-inc/investment-income-interest https://stock.noler.com/us/stock/bioclinica-inc/lease-and-rental-expense https://stock.noler.com/us/stock/bioclinica-inc/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/bioclinica-inc/line-of-credit-facility-unused-capacity-commitment-fee-percentage https://stock.noler.com/us/stock/bioclinica-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/bioclinica-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/bioclinica-inc/net-change-in-cash https://stock.noler.com/us/stock/bioclinica-inc/net-income https://stock.noler.com/us/stock/bioclinica-inc/noncash-or-part-noncash-acquisition-accounts-receivable-acquired https://stock.noler.com/us/stock/bioclinica-inc/noncash-or-part-noncash-acquisition-fixed-assets-acquired https://stock.noler.com/us/stock/bioclinica-inc/noncash-or-part-noncash-acquisition-intangible-assets-acquired https://stock.noler.com/us/stock/bioclinica-inc/noncash-or-part-noncash-acquisition-other-assets-acquired https://stock.noler.com/us/stock/bioclinica-inc/noncash-or-part-noncash-acquisition-payables-assumed https://stock.noler.com/us/stock/bioclinica-inc/oci-derivatives-qualifying-as-hedges-net-of-tax https://stock.noler.com/us/stock/bioclinica-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/bioclinica-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-change https://stock.noler.com/us/stock/bioclinica-inc/operating-cash-flow https://stock.noler.com/us/stock/bioclinica-inc/operating-costs-and-expenses https://stock.noler.com/us/stock/bioclinica-inc/operating-income https://stock.noler.com/us/stock/bioclinica-inc/operating-lease-payments-due https://stock.noler.com/us/stock/bioclinica-inc/operating-lease-payments-due-in-rolling-after-year-five https://stock.noler.com/us/stock/bioclinica-inc/operating-lease-payments-due-in-rolling-year-five https://stock.noler.com/us/stock/bioclinica-inc/operating-lease-payments-due-in-rolling-year-four https://stock.noler.com/us/stock/bioclinica-inc/operating-lease-payments-due-in-rolling-year-three https://stock.noler.com/us/stock/bioclinica-inc/operating-lease-payments-due-in-rolling-year-two https://stock.noler.com/us/stock/bioclinica-inc/operating-leases-future-minimum-payments-next-rolling-twelve-months https://stock.noler.com/us/stock/bioclinica-inc/operating-loss-carryforwards-valuation-allowance https://stock.noler.com/us/stock/bioclinica-inc/option-indexed-to-issuers-equity-settlement-alternatives-cash-at-fair-value https://stock.noler.com/us/stock/bioclinica-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/bioclinica-inc/other-current-liabilities https://stock.noler.com/us/stock/bioclinica-inc/other-noncurrent-assets https://stock.noler.com/us/stock/bioclinica-inc/other-noncurrent-liabilities https://stock.noler.com/us/stock/bioclinica-inc/other-receivables-gross-current https://stock.noler.com/us/stock/bioclinica-inc/other-restructuring-costs https://stock.noler.com/us/stock/bioclinica-inc/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/bioclinica-inc/paid-in-capital-tax-effect-from-share-based-compensation https://stock.noler.com/us/stock/bioclinica-inc/payments-for-derivative-instrument-investing-activities https://stock.noler.com/us/stock/bioclinica-inc/payments-for-restructuring https://stock.noler.com/us/stock/bioclinica-inc/payments-for-software https://stock.noler.com/us/stock/bioclinica-inc/payments-to-acquire-equipment-on-lease https://stock.noler.com/us/stock/bioclinica-inc/preferred-shares-facts https://stock.noler.com/us/stock/bioclinica-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/bioclinica-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/bioclinica-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/bioclinica-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/bioclinica-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/bioclinica-inc/pretax-income-domestic https://stock.noler.com/us/stock/bioclinica-inc/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/bioclinica-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/bioclinica-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/bioclinica-inc/property-plant-equipment https://stock.noler.com/us/stock/bioclinica-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/bioclinica-inc/public-float https://stock.noler.com/us/stock/bioclinica-inc/reimbursement-revenue https://stock.noler.com/us/stock/bioclinica-inc/repayments-of-debt-and-capital-lease-obligations https://stock.noler.com/us/stock/bioclinica-inc/restricted-stock-value-shares-issued-net-of-tax-withholdings https://stock.noler.com/us/stock/bioclinica-inc/restructuring-charges https://stock.noler.com/us/stock/bioclinica-inc/retained-earnings https://stock.noler.com/us/stock/bioclinica-inc/revenue https://stock.noler.com/us/stock/bioclinica-inc/sale-leaseback-transaction-deferred-gain-gross https://stock.noler.com/us/stock/bioclinica-inc/sale-leaseback-transaction-gross-proceeds https://stock.noler.com/us/stock/bioclinica-inc/sale-leaseback-transaction-net-proceeds https://stock.noler.com/us/stock/bioclinica-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/bioclinica-inc/sales-revenue-services-net https://stock.noler.com/us/stock/bioclinica-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/bioclinica-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/bioclinica-inc/sec-filings-10-k https://stock.noler.com/us/stock/bioclinica-inc/sec-filings-10-q https://stock.noler.com/us/stock/bioclinica-inc/sec-filings-10ksb https://stock.noler.com/us/stock/bioclinica-inc/sec-filings-10qsb https://stock.noler.com/us/stock/bioclinica-inc/sec-filings-15-12g https://stock.noler.com/us/stock/bioclinica-inc/sec-filings-25-nse https://stock.noler.com/us/stock/bioclinica-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/bioclinica-inc/sec-filings-8-a12g https://stock.noler.com/us/stock/bioclinica-inc/sec-filings-8-k https://stock.noler.com/us/stock/bioclinica-inc/sec-filings-ars https://stock.noler.com/us/stock/bioclinica-inc/sec-filings-certamx https://stock.noler.com/us/stock/bioclinica-inc/sec-filings-ct-order https://stock.noler.com/us/stock/bioclinica-inc/sec-filings-def-14a https://stock.noler.com/us/stock/bioclinica-inc/sec-filings-defa14a https://stock.noler.com/us/stock/bioclinica-inc/sec-filings-defc14a https://stock.noler.com/us/stock/bioclinica-inc/sec-filings-dfan14a https://stock.noler.com/us/stock/bioclinica-inc/sec-filings-dfrn14a https://stock.noler.com/us/stock/bioclinica-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/bioclinica-inc/sec-filings-prem14a https://stock.noler.com/us/stock/bioclinica-inc/sec-filings-sc-14d9 https://stock.noler.com/us/stock/bioclinica-inc/sec-filings-sc-to-c https://stock.noler.com/us/stock/bioclinica-inc/sec-filings-sc-to-t https://stock.noler.com/us/stock/bioclinica-inc/sec-filings-sc14d9c https://stock.noler.com/us/stock/bioclinica-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/bioclinica-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/bioclinica-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/bioclinica-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/bioclinica-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/bioclinica-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/bioclinica-inc/selling-and-marketing-expense https://stock.noler.com/us/stock/bioclinica-inc/severance-costs https://stock.noler.com/us/stock/bioclinica-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-lower-range-limit https://stock.noler.com/us/stock/bioclinica-inc/share-based-compensation-shares-authorized-under-stock-option-plans-exercise-price-range-upper-range-limit https://stock.noler.com/us/stock/bioclinica-inc/shareholders-equity https://stock.noler.com/us/stock/bioclinica-inc/shares-authorized https://stock.noler.com/us/stock/bioclinica-inc/shares-issued https://stock.noler.com/us/stock/bioclinica-inc/shares-paid-for-tax-withholding-for-share-based-compensation https://stock.noler.com/us/stock/bioclinica-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/bioclinica-inc/stock-award-fair-value-assumptions-expected-volatility-rate-maximum https://stock.noler.com/us/stock/bioclinica-inc/stock-award-fair-value-assumptions-expected-volatility-rate-minimum https://stock.noler.com/us/stock/bioclinica-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-maximum https://stock.noler.com/us/stock/bioclinica-inc/stock-award-fair-value-assumptions-risk-free-interest-rate-minimum https://stock.noler.com/us/stock/bioclinica-inc/stock-based-compensation https://stock.noler.com/us/stock/bioclinica-inc/stock-compensation-cash-received-from-exercise-of-stock-options https://stock.noler.com/us/stock/bioclinica-inc/stock-compensation-tax-benefit-realized-from-exercise-of-stock-options https://stock.noler.com/us/stock/bioclinica-inc/stock-compensation-unrecognized-cost-stock-options https://stock.noler.com/us/stock/bioclinica-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/bioclinica-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/bioclinica-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/bioclinica-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/bioclinica-inc/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/bioclinica-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/bioclinica-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/bioclinica-inc/stock-options-vested-and-expected-to-vest-exercisable-average-exercise-price https://stock.noler.com/us/stock/bioclinica-inc/stock-options-vested-and-expected-to-vest-exercisable-number https://stock.noler.com/us/stock/bioclinica-inc/stock-repurchase-program-authorized-amount https://stock.noler.com/us/stock/bioclinica-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/bioclinica-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/bioclinica-inc/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/bioclinica-inc/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/bioclinica-inc/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/bioclinica-inc/total-assets https://stock.noler.com/us/stock/bioclinica-inc/total-liabilities https://stock.noler.com/us/stock/bioclinica-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/bioclinica-inc/treasury-stock-retired-cost-method-amount https://stock.noler.com/us/stock/bioclinica-inc/treasury-stock-shares https://stock.noler.com/us/stock/bioclinica-inc/treasury-stock-value https://stock.noler.com/us/stock/bioclinica-inc/unbilled-contracts-receivable https://stock.noler.com/us/stock/bioclinica-inc/unrealized-gain-loss-on-derivatives https://stock.noler.com/us/stock/bioclinica-inc/unrecognized-tax-benefits https://stock.noler.com/us/stock/bioclinica-inc/utb-decrease-from-prior-year-positions https://stock.noler.com/us/stock/bioclinica-inc/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/bioclinica-inc/utb-income-tax-penalties-expense https://stock.noler.com/us/stock/bioclinica-inc/utb-increase-from-current-year-positions https://stock.noler.com/us/stock/bioclinica-inc/utb-increase-from-prior-year-positions https://stock.noler.com/us/stock/bioclinica-inc/utb-that-would-impact-effective-tax-rate